-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
Kairos Pharma, LTD. quarterly Liabilities history and change rate from Q4 2023 to Q4 2024.
- Kairos Pharma, LTD. Liabilities for the quarter ending 31 Dec 2024 was $992K, a 67.4% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Change (%)